| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||



* National Institute for Medical Research, London, United Kingdom;
Bioinformatics Unit, Faculty of Sciences, Free University of Amsterdam, Amsterdam, The Netherlands;
Department of Chemistry, University of British Columbia, Vancouver, British Columbia, Canada; and
Biological Nuclear Magnetic Resonance Unit, Institute for Clinical Research, Medical School, University of Birmingham, Birmingham, United Kingdom
Correspondence: Address reprint requests to Franca Fraternali, Mill Hill, London NW7 1AA, London, UK. Tel.: 44-2088162250; Fax: 44-208906477; E-mail: ffranca{at}nimr.mrc.ac.uk.
| ABSTRACT |
|---|
|
|
|---|
30° with respect to the membrane normal, in very good agreement with experimental data. The tilted insertion of the native sequence peptide leads to membrane bilayer thinning and the calculated order parameters show larger disorder of the alkyl chains. These results indicate that the lipid packing is perturbed by the fusion peptide and could be used to explain membrane fusion. For the nonfusogenic sequences investigated, it was found that most of them equilibrate parallel to the interface plane and do not adopt a tilted conformation. The presence of a charged residue at the beginning of the sequence (G1E mutant) resulted in a more difficult case, and the outcomes do not fall straightforwardly into the general picture. Sequence searches have revealed similarities of the fusion peptide of influenza haemagglutinin with peptide sequences such as segments of porin, amyloid
ß peptide, and a peptide from the prion sequence. These results confirm that the sequence can adopt different folds in different environments. The plasticity and the conformational dependence on the local environment could be used to better understand the function of fusion peptides. | INTRODUCTION |
|---|
|
|
|---|
-helical secondary structure and interactions of the charged residues with the phosphate groups of the lipids. This structure is different from the corresponding region in the native structure, suggesting a structural plasticity of the sequence that may be crucial for the fusion process. Spin-label electron paramagnetic resonance (EPR) (Macosko et al., 1997| METHODS |
|---|
|
|
|---|
Molecular dynamics simulations
To analyze the behavior of fusogenic and nonfusogenic sequences, we selected the following fusion peptides (Table 1): HA5 and G4E from the H3 influenza haemagglutinin, H9 from the H9 influenza haemagglutinin, and H2B from influenza B. For the H3 nonfusogenic mutant sequences we studied G1L, G4V,
G1, and G1E. These latter four peptide sequences have been shown to result in a loss of fusion activity in experiments using synthetic peptides and full-length expressed haemagglutinin (Steinhauer et al., 1995
). However, in the case of G1L generated by reverse genetics it was possible to rescue the virus but this replicated to a significantly lower level than wild-type virus, therefore indicating that this mutant is greatly impaired but not totally fusion inactive in the virus (Cross et al., 2001
). The initial structures for the simulations are the Protein Data Bank (PDB) files 1IBN (pH 5.0) and 1IBO (pH 7.4), hereafter denoted as HA5 and HA7 (Han et al., 2001
). All the mutants have been modeled on the initial structure of HA5. The peptides were inserted in a fully equilibrated 128 POPC lipid bilayer (Tieleman et al., 1999
). The Glu11 residue was placed in the bilayer at the level of the lipid phosphate groups (Han et al., 2001
). The coordinates of the 128 POPC bilayer were used as a solvating box for the peptide;
10 lipid molecules were removed in the upper leaflet to accommodate the peptide for each of the systems. Given that the peptide is relatively small, more sophisticated procedures (Faraldo-Gomez et al., 2002
) were not necessary in this case. Previous work on the fusion peptide gp41 (Kamath and Wong, 2002
; Wong, 2003
) used a similar approach. The peptides were simulated with charged N- and C termini for the native sequence (referred to as HA5_c); for all the other simulations neutral N- and C termini were used. Neutral termini allowed us to insert the peptide deeply into the membrane to see if the peptide orientation would equilibrate to the experimentally observed parameters. Thus, sampling was not biased toward the initial positioning of the tilt angle of the 1IBN and 1IBO structures (see Fusogenic and nonfusogenic mutants section for a discussion of this point). Each system was then solvated with water, resulting in a total of
19,000 atoms (box dimensions were 6.2 x 6.7 x 6.2 nm3) and then subjected to 500 ps of solute-restrained MD simulations to allow the lipid molecules to relax. The final structures were submitted to 5-ns simulation runs. Longer simulations were performed on the HA5 peptide, up to 10 ns, as well as simulations in a different bilayer (palmitoyl-oleoyl-phosphatidylethanolamine) and the average properties (tilting angle, percentage of helical structure) did not change significantly. In the past Brunner (1989)
showed by photolabeling techniques that the peptide only penetrates one leaflet of the bilayer; therefore, we decided to start from an asymmetric positioning of the peptide in the membrane. The slight asymmetry of the bilayer seemed not to have any effects on the conformational behavior of the peptide. Given that the average properties for all peptides studied here did not vary significantly after 3 ns time, only 5 ns of simulation data was used for the analysis. This allowed us to maximize the number of mutants that could be studied. MD simulations were performed using GROMACS (Berendsen et al., 1995
). The LINCS algorithm was used to constrain all bond lengths within the lipids. A cutoff of 0.9 nm for Coulomb and Lennard-Jones interactions was used and particle mesh Ewald (Essmann et al., 1995
) was used to calculate the remaining electrostatic contributions on a grid with 0.12 nm spacing. NPT conditions (i.e., constant number of particles, pressure, and temperature) were used in the simulations. A constant pressure of 1 bar in all three directions was used, with a coupling constant of 1.0 ps (Berendsen et al., 1984
). Water, lipids, and protein were coupled separately to a temperature bath at 300 K with a coupling constant of 0.1 ps. The velocity of the atoms was not rescaled during the simulation. The lipid parameters were as in previous MD studies of lipid bilayers (Tieleman et al., 1999
) and the GROMOS96 force field (43al) was used for the peptide (van Gunsteren et al., 1996
). The SPC water model was used for the solvent (Berendsen et al., 1981
). Analysis programs from GROMACS were used, together with our own programs (for tilt angle and secondary-structure calculations). The bilayer thickness was determined as the average difference of the y coordinates (the membrane plane was in xz orientation) between the phosphorus atoms of the upper and lower leaflets. The depth of residues inside the bilayer was determined as the average difference in the y coordinates of each residue's C
atom and the phosphorus atoms of the upper leaflet.
|
| RESULTS |
|---|
|
|
|---|
ß peptide and with a peptide from the prion sequence have been already pointed out elsewhere (Crescenzi et al., 2002
|
-helical for both conformers, but the pH 5.0 conformer presents a short stretch of 310 helix from residues 1318. The NMR study in SDS micelles of the E5 peptide (Hsu et al., 2002
atoms is 0.96 Å between HA5_NMR and E5. This structural similarity indicates that the orientation and structure of the first 11 residues and of the Glu15 residue are the same. Specifically, Glu 11 and Glu 15 point toward the phosphate groups of the bilayer interface in both structures and the Phe residues are on the opposite side pointing toward the lipid tails in the membrane.
All these considerations seem to imply that the N-terminal 11 residues of the two fusion peptides are in a helical conformation and that residues 11 and 15 should be located at the phosphate-water interface. We therefore constructed two structures starting from the coordinates of HA5_NMR and HA7_NMR, inserted into a preformed POPC lipid bilayer (see Methods section) and simulated each system for 5 ns (the corresponding conformers are referred to as HA5 and HA7). The percentage of secondary-structure elements for the analyzed structures is shown in Fig. 2. Panel a illustrates values for the experimentally determined structures and panel b for the simulated ones averaged over the last 2 ns. The general pattern helix-bend (turn)-helix of the HA5_NMR is maintained for HA5, with a percentage of residues in a helical conformation being slightly higher than for the experimentally determined structures. The HA7 starting structure remains disordered for the segment 1220, suggesting that if the peptide were to enter the membrane in a partially disordered state, the refolding process would be prevented by the competing favorable interactions with the polar headgroups at the membrane interface. Residues 10 and 11 are more ordered in the simulated peptides, since, as already observed for HA5, the method tends to overestimate the helical content. In Fig. 3, the NMR structures are compared with the simulated ones. In Table 2, some structural parameters for HA5 and HA7 are reported. The helical content measured from the NMR structures HA5_NMR and HA7_NMR are close to the ones measured from the 5-ns trajectories, with the HA5 values higher than the HA7 ones. As already mentioned, the helical contents derived from the simulations are often higher than the measured ones, but the length of the simulation does not allow us to observe statistically relevant unfolding-refolding events. We are not able, on the basis of our simulations, to differentiate, with respect to fusogenic activity, between HA5 and HA7. We have to stress, nevertheless, some contradiction in the literature about the definition of active forms at different pH for the mechanism of insertion. In a pioneering study of the membrane-binding conformational properties of influenza haemagglutinin (Lear and De Grado, 1987
) it was clearly shown that the fusion peptide could fuse vesicles at a rate that is independent of pH between 5.0 and 7.0. Later on, other studies (Han et al., 2001
; Epand et al., 2001
) have stressed the importance of a low pH for the fusogenic activity to occur. Our simulations are performed at constant pH and therefore the only difference between the HA5 and the HA7 conformers is their starting conformation. It would be beyond the scope of our simulations to claim a difference in activity for the same sequence. Under our conditions both conformers adopt a tilted orientation and the HA7 structure results are more disordered and generally less stable, but this could also be due to a less folded starting structure. In principle, an infinitely long simulation should be able to yield the equilibrium conformation of the two conformers. In the past, simulations on peptides and proteins have successfully produced unfolding-refolding events, but these were performed on longer timescales (at least 10 times longer) (Daura et al., 1998
, 1999
) or with more efficient sampling procedures (Kleinjung et al., 2003
). None of these simulations was perfomed in an explicit membrane environment. The analysis of the equilibrium between the two conformers studied here would be interesting subject matter for future studies.
|
|
|
8 Å, which is more pronounced for HA7 than for HA5. This difference may be an artifact since the method used to estimate the membrane thickness is based on average distances, which can significantly oscillate during the simulation, especially in the case of the more disordered HA7. This structure has residue Glu15 pointing toward the hydrophobic face of the membrane (as in the NMR structure). This residue experiences a significant rearrangement that causes a considerable displacement of the phosphate groups in close proximity to Glu15. As a consequence only qualitative observations can be made about the relative thinning effect. Overall, there is a significant change in bilayer thickness for the simulations with peptide over those with POPC alone. In general, the thinning could be related either to the interaction of polar residues in the peptides, which, in the process of insertion into the membrane, would "pull down" the phosphate groups of the upper leaflet, or to the disorder in the hydrophobic tails generated by the peptide. This latter point will be discussed later in more detail.
Fusogenic and nonfusogenic mutants
All the selected sequences have been subjected to 5ns of simulation in POPC and water. The final snapshots from the simulations are shown in Fig. 4. For simplicity only the upper layer of water and phosphorus atoms (yellow spheres) is represented. The panels on the left correspond to fusogenic sequences, whereas the ones on the right correspond to nonfusogenic sequences. It can be easily observed that fusogenic peptides preserve in general the inverse V shape of the starting structure, and all insert with a tilt angle. The nonfusogenic peptides tend to migrate to the interface and, due to their amphiphilic nature, tend to increase their helical content. This result agrees with previous NMR results of fusogenic and nonfusogenic mutants, where the first residue was mutated, in dodecylphosphocholine micelles (Tamm, 2003
). The final structures from the MD simulations of all the sequences have been superimposed onto the HA5 starting one. The average RMSD on all C
is
2.5 Å with a better superimposition for the first 11 residues. The average RMSD on all C
in the NMR bundle structures from Han et al. (2001)
is at most
2.2 Å; therefore it can be assumed that the mobility of the structures in the lipid environment has not influenced the structure substantially.
|
The peptide H2B inserts most deeply into the membrane. This could be attributed to the presence of two phenylalanines at the N-terminal region of the sequence, which increases the hydrophobic moment of the inserting helix and stabilizes interactions with the lipid chains. In Fig. 5, the tilt angles of the HA5 and HA7 and G4E peptides and of the fusion-impaired mutants G1L,
G1, and G4V are reported. The experimental values reported refer to two different experimental immersion depth measurements for HAFP, obtained from EPR data on singly spin-labeled peptides (Macosko et al., 1997
) (exp1) and by mapping NMR data onto the best-fit EPR data (Han et al., 2001
) (exp2). The fusogenic peptides equilibrate their tilt angles after
3 ns to values very close to the experimental ones (between
25° and
38°). It is important to stress that tilt-angle values stabilize after
34 ns, which is another reason why all our simulations were performed for at least 5 ns. Recent work demonstrated that to study the mechanism of insertion of peptides into a lipid bilayer, 30 ns of simulation are necessary (Shepherd et al., 2003
), but the purpose of our study is the comparison between different systems of peptides already inserted into the bilayer, and the equilibration of the tilt angle supports our choice of 5 ns. While we were completing this work, a study on the bilayer conformation of the native sequence of the fusion peptide appeared (Huang et al., 2004
), where the peptide has been simulated in two different protonation states for the N-termini for 19 ns. The final structure and position of the peptide in this study is, as far as we can judge, not very different from ours; therefore the shorter simulation time chosen should not influence dramatically the structure and positioning of the peptide, and our comparison across mutants should be not substantially affected.
|
To describe the insertion mode of the peptide, we report in Fig. 6 the depth of insertion of the 11 N-terminal residues. The reason we focused on these residues is that in all sequences this segment is mostly in helical conformation. We can see that the fusion-impaired mutant G1L is less deeply inserted. This result has been confirmed in experimental data, which has shown that for G1S, G1E, and G1L the depth of insertion and lipid perturbation were lower than for the native sequence (Wu et al., 2003
). From our simulations, we can derive that the tilted insertion is mainly due to residues 3, 5, and 6. The most deeply inserted, Ile6, is located at
9 Å depth, in good agreement with experimental data (Macosko et al., 1997
; Zhou et al., 2000
; Han et al., 2001
). By inserting deeper into the bilayer and in a tilted way, the fusogenic peptides may destabilize the membrane, promoting membrane fusion. The tilted insertion and perturbation of the membrane has been already illustrated in other computational studies (Lins et al., 2001
).
|
|
|
50° was imposed. For G1E, the presence of the glutamate residue (which is protonated because it is positioned deep in the apolar lipidic phase) strongly stabilizes the helix dipole moment and therefore the process of migration is very slow. We have extended this simulation to 10 ns and as can be seen in Fig. 9 the tilt angle still oscillates around values larger than the ones observed for the other studied peptides. At the end of the 10-ns simulation the Glu residue is still in oblique orientation (Fig. 9), because water molecules and phosphate groups have been dragged down toward the apolar phase, attracted by the polar field of the Glu residue, as shown in the right panel of Fig. 9. To speed up a process that would require a very long simulation time to be observed, we started from a configuration with a tilt corresponding to the minimum value observed during the 10-ns period and performed an additional 5 ns of simulation. As expected for a nonfusogenic peptide, under these conditions G1E migrated toward the interface and reached the conformation shown in Fig. 4. Although these conditions are not exactly the same as those used for the other peptides, it should be noted that we are trying to simulate a process that is opposite to the one naturally occurring during the insertion of the peptides into the membrane. In reality the peptide would have to pass through the polar phase and then reach the apolar lipidic tails. During this process a charged residue would presumably be trapped by favorable interactions with the aqueous phase and it would not tilt into the membrane.
|
| CONCLUSIONS |
|---|
|
|
|---|
ß peptide and with a peptide from the prion protein was detected, and the structural plasticity of the FP could be a characteristic required for proteins that undergo large conformational transitions, leading in some cases to a pathogenic form.
We suggest that the amino acid composition could be associated with structural mobility and pore-forming ability. The amphiphilic character of the sequence and the glycine pattern favor helical structures in hydrophobic environments. Our simulated peptides confirm previous structural observations of highly amphipathic conformations adopting an inverse V-shaped structure. One of the most critical parameters in exhibiting fusogenic behavior may be the insertion at an angle to the membrane to perturb the bilayer. In particular, the presence of a fairly stable helix spanning the first 11 N-terminal residues seems necessary to stabilize the tilt angle to a value of
30°. This tilted insertion is mainly due to residues 3, 5, and 6, in line with experimental EPR measurements (Macosko et al., 1997
; Han et al., 2001
), and especially good agreement is found for residue 6, which is inserted to a depth of 9 Å. Lower order parameter values (in magnitude) are observed for fusogenic peptides versus nonfusogenic ones, indicating that the tilted insertion increases the amount of disorder in the leaflet. The C-terminal segment can be partially unfolded without modifying the tilt of the first segment. The lipid bilayer is therefore perturbed by the presence of the FPs and a thinning of
8 Å is observed after 5 ns of simulation for either HA5 and HA7, suggesting that the most important factors determining fusogenicity may be found in the interactions of the first 11 residues with the bilayer and not in the degree of secondary structure of the C-terminal segment. This may indicate that the fusogenic activity of a peptide is correlated with the amino acid composition of the first 11 residues. The nonfusogenic mutants tend to migrate to the polar interface and lose the V-shaped structure, in agreement with Fourier transformed infrared spectroscopy data (Han et al., 2001
). It is important to recall that fusion peptides are only simplified models of the entire system and therefore cannot entirely describe the complexity of the process. More structural studies are needed to fully understand the mechanism of entry of enveloped viruses into the host membrane.
| ACKNOWLEDGEMENTS |
|---|
|
|
|---|
L.V. acknowledges a grant from the University of Salerno, Italy. S.K.S. thanks the Natural Sciences and Engineering Research Council of Canada for a University Faculty Award. This work was supported by the Medical Research Council.
Submitted on April 16, 2004; accepted for publication September 20, 2004.
| REFERENCES |
|---|
|
|
|---|
Benchor, D., and N. Ben-Tal. 2001. Implicit solvent model studies of the interactions of the influenza hemagglutinin fusion peptide with lipid bilayers. Biophys. J. 80:643655.
Benson, D. A., Karsch-Mizrachi, I., Lipman, D. J., Ostell, J., B. A. Rapp, and D. L. Wheeler. 2002. GenBank. Nucleic Acids Res. 30:1720.
Berendsen, H., J. Postma, W. van Gunsteren, A. DiNola, and J. Haak. 1984. Molecular dynamics with coupling to an external bath. J. Chem. Phys. 81:36843690.[CrossRef]
Berendsen, H., J. Postma, W. van Gunsteren, and J. Hermans. 1981. Interaction models for water in relation to protein hydration. In Intermolecular Forces. B. Pullman, editor. Reidel, Dordrecht, The Netherlands.
Berendsen, H., D. van der Spoel, and R. van Drunen. 1995. Gromacs: a message-passing parallel molecular dynamics implementation. Comput. Phys. Commun. 95:4356.
Bizebard, T., B. Gigant, P. Rigolet, B. Rasmussen, O. Diat, P. Boseke, S. A. Wharton, J. J. Skehel, and M. Knossow. 1995. Structure of influenza haemagglutinin complexed with a neutralizing antibody. Nature. 376:9294.[CrossRef][Medline]
Boeckmann, B., A. Bairoch, R. Apweiler, M. C. Blatter, A. Estreicher, E. Gasteiger, M. J. Martin, K. Michoud, C. O'Donovan, I. Phan, S. Pilbout, and M. Schneider. 2003. The SWISS-PROT protein knowledge base and its supplement TrEMBL in 2003. Nucleic Acids Res. 31:365370.
Bradshaw, J. P., M. J. M. Darkes, T. A. Harroun, J. Katsaras, and R. M. Epand. 1998. Structure of the haemagglutinin precursor cleavage site, a determinant of influenza pathogenicity and the origin of the labile conformation. Cell. 95:409417.[CrossRef][Medline]
Brunner, J. 1989. Testing topological models for the membrane penetration of the fusion peptide of influenza virus hemagglutinin. FEBS Lett. 257:369372.[CrossRef][Medline]
Bullough, P. A., F. M. Hughson, J. J. Skehel, and D. C. Wiley. 1994. Structure of influenza haemagglutinin at the pH of membrane fusion. Nature. 371:3743.[CrossRef][Medline]
Chen, J., K. H. Lee, D. A. Steinhauer, D. J. Stevens, J. J. Skehel, and D. C. Wiley. 1998. Structure of the haemagglutinin precursor cleavage site, a determinant of influenza pathogenicity and the origin of the labile conformation. Cell. 95:409417.[CrossRef][Medline]
Crescenzi, O., Tomaselli, S., Guerrini, R., Salvadori, S., D'Ursi, A. M., Temussi, P. A., and D. Picone. 2002. Solution structure of the alzheimer amyloid ß-peptide in an apolar microenvironment. Eur. J. Biochem. 269:56425648.[Medline]
Cross, K. J., S. A. Wharton, J. J. Skehel, D. C. Wiley, and D. A. Steinhauer. 2001. Studies on influenza haemagglutinin fusion peptide mutants generated by reverse genetics. EMBO J. 20:44324442.[CrossRef][Medline]
Daura, X., B. Jaun, W. F. van Gunsteren, and A. E. Mark. 1998. Reversible peptide folding in solution by molecular dynamics simulations. J. Mol. Biol. 280:925932.[CrossRef][Medline]
Daura, X., W. F. van Gunsteren, and A. E. Mark. 1999. Folding-unfolding thermodynamics of a ß-heptapeptide from equilibrium simulations. Proteins. 34:269280.[CrossRef][Medline]
Del Angel, V. D., F. Dupuis, J. P. Mornon, and I. Callebaut. 2002. Viral fusion peptides and identification of membrane-interacting segments. Biochem. Biophys. Res. Commun. 293:11531160.[CrossRef][Medline]
Dubovskii, P. V., H. Li, S. Takahashi, A. S. Arseniev, and K. Akasaka. 2000. Structure of an analog of fusion peptide from hemagglutinin. Protein Sci. 9:786798.[Abstract]
Efremov, R. G., D. E. Nolde, P. E. Volynsky, A. A. Chernyavsky, P. V. Dubovskii, and A. S. Arseniev. 1999. Factors important for fusogenic activity of peptides: molecular modeling study of analogs of fusion peptide of influenza virus hemagglutinin. FEBS Lett. 462:205210.[CrossRef][Medline]
Epand, R. M. 2003. Fusion peptides and the mechanism of viral fusion. Biochim. Biophys. Acta. 1614:116121.[Medline]
Epand, R. M., R. F. Epand, I. Martin, and J. M. Ruysschaert. 2001. Membrane interactions of mutated forms of the influenza fusion peptide. Biochemistry. 40:88008807.[CrossRef][Medline]
Essmann, U., L. Perera, M. Berkowitz, T. Darden, H. Lee, and L. G. Pedersen. 1995. A smooth particle mesh Ewald method. J. Chem. Phys. 103:85778593.[CrossRef]
Faraldo-Gomez, J. D., G. R. Smith, and M. S. Sansom. 2002. Setting up and optimization of membrane protein simulations. Eur. Biophys. J. 31:217227.[CrossRef][Medline]
Forloni, G., N. Angeretti, R. Chiesa, E. Monzani, M. Salmona, O. Bugiani, and F. Tavaglini. 1993. Neurotoxicity of a prion protein fragment. Nature. 632:543546.
Gething, M. J., R. W. Doms, D. York, and J. M. White. 1986. Studies on the mechanism of membrane fusion: site-specific mutagenesis of the hemagglutinin of influenza virus. J. Cell Biol. 102:1123.
Graves, P. N., J. L. Schulman, J. F. Young, and P. Palese. 1983. Preparation of influenza virus subviral particles lacking the HA1 subunit of hemagglutinin: unmasking of cross-reactive ha2 determinants. Virology. 126:106116.[CrossRef][Medline]
Han, X., J. H. Bushweller, D. S. Cafiso, and L. Tamm. 2001. Membrane structure and fusion-triggering conformational change of the fusion domain from influenza hemagglutinin. Nat. Struct. Biol. 8:715720.[CrossRef][Medline]
Han, X., and L. Tamm. 2000. A host-guest system to study structure-function relationships of membrane fusion peptides. Proc. Natl. Acad. Sci. USA. 97:1309713102.
Henikoff, S., and J. G. Henikoff. 1992. Amino acid substitution matrices from protein blocks. Proc. Natl. Acad. Sci. USA. 89:1091510919.
Heringa, J. 1999. Two strategies for sequence comparison: profile-preprocessed and secondary structure-induced multiple alignment. Comput. Chem. 23:341364.[CrossRef][Medline]
Heringa, J. 2002. Local weighting schemes of protein multiple sequence alignment. Comput. Chem. 26:459477.[CrossRef][Medline]
Hsu, C. H., S. H. Wu, D. K. Chang, and C. Chen. 2002. Structural characterizations of fusion peptide analogs of influenza virus hemagglutinin. J. Biol. Chem. 277:2272522733.
Huang, Q., C. L. Chen, and A. Hermann. 2004. Bilayer conformation of fusion peptide influenza virus hemagglutinin: a molecular dynamics study. Biophys. J. 87:1422.
Kamath, S., and T. C. Wong. 2002. Membrane structure of the human immunodeficiency virus gp41 fusion domain by molecular dynamics simulations. Biophys. J. 83:135143.
Kinoshita, K., S. Furuike, and M. Yamazaki. 1998. Intermembrane distance in multilamellar vesicles of phosphatidylcholine depends on the interaction free energy between solvents and the hydrophilic segments of the membrane surface. Biophys. Chem. 74:237249.[CrossRef][Medline]
Kleiger, G., R. Grothe, P. Mallick, and D. Eisenberg. 2002. The GXXXG and AXXXA: common
-helical interaction motifs in proteins, particularly in extremophiles. Biochemistry. 41:59905997.[CrossRef][Medline]
Kleinjung, J., F. Fraternali, S. R. Martin, and P. M. Bayley. 2003. Thermal unfolding simulations of apo-calmodulin using leap-dynamics. Proteins. 50:648656.[CrossRef][Medline]
Lau, W. L., D. Ege, J. D. Lear, D. Hammer, and W. F. De Grado. 2004. Oligomerization of fusogenic peptides promotes membrane fusion by enhancing membrane destabilization. Biophys. J. 86:272284.
Lear, J. D., and W. F. De Grado. 1987. Membrane binding and conformational properties of peptide representing the amino terminus of influenza virus HA2. J. Biol. Chem. 262:65006505.
Li, Y., X. Han, and L. Tamm. 2003. Thermodynamics of fusion peptide-membrane interactions. Biochemistry. 42:72457251.[CrossRef][Medline]
Lin, K. X., J. Kleinjung, W. R. Taylor, and J. Heringa. 2003. Testing homology with CAO: a contact-based Markov model of protein evolution. Comput. Biol. Chem. 27:93102.[CrossRef][Medline]
Lins, L., Charloteaux, B., Thomas, A., and R. Brasseur. 2001. Computational study of lipid-destabilising protein fragments: towards a comprehensive view of tilted peptides. Proteins. 44:435447.[CrossRef][Medline]
MacKenzie, K. R., J. H. Prestegard, and D. M. Engelman. 1997. A transmembrane helix dimer:structure and implications. Science. 276:131133.
Macosko, J. C., C. Kim, and Y. Shin. 1997. The membrane topology of the fusion peptide region of influenza hemagglutinin determined by spin-labeling EPR. J. Mol. Biol. 267:11391148.[CrossRef][Medline]
Massi, F., J. W. Peng, J. P. Lee, and J. E. Straub. 2001. Simulation study of the structure and dynamics of the Alzheimer's amyloid peptide congener in solution. Biophys. J. 80:3144.
Murata, M., Y. Sugahara, S. Takahashi, and S. Ohnishi. 1987. pH-dependent membrane fusion activity of a synthetic twenty amino acid peptide with the same sequence as that of the hydrophobic segment of influenza virus hemagglutinin. J. Biochem. 102:957962.
Nobusawa, E., T. Aoyama, H. Kato, Y. Suzuki, Y. Tateno, and K. Nakajima. 1991. Comparison of complete amino acid sequences and receptor-binding properties among 13 serotypes of hemgglutinins of influenza A viruses. Virology. 182:475485.[CrossRef][Medline]
Qiao, H., R. T. Armstrong, G. B. Melikyan, F. S. Cohen, and J. M. White. 1999. A specific point mutant at position 1 of the influenza hemagglutinin fusion peptide displays a hemifusion phenotype. Mol. Biol. Cell. 8:27592769.
Russ, W. P., and D. M. Engelman. 2000. The GxxxG motif: A framework for transmembrane helix-helix association. J. Mol. Biol. 296:911919.[CrossRef][Medline]
Seelig, A., and J. Seelig. 1977. Effect of a single cis double bond on the structure of a phospholipid bilayer. Biochemistry. 16:4550.[CrossRef][Medline]
Seelig, A., and J. Seelig. 1980. Lipid conformation in model membranes and biological membranes. Q. Rev. Biophys. 13:1961.[Medline]
Seelig, J., S. Nebel, P. Ganz, and C. Bruns. 1993. Electrostatic and nonpolar peptide-membrane interactions. lipid binding and functional properties of somatostatin analogues of charge z=+1 to z=+3. Biochemistry. 32:97149721.[CrossRef][Medline]
Shepherd, C. M., H. J. Vogel, and D. P. Tieleman. 2003. Interactions of the designed antimicrobial peptide mb21 and truncated dermaseptin s3 with lipid bilayers: molecular-dynamics simulations. Biochem. J. 370:233243.[CrossRef][Medline]
Skehel, J. J., P. M. Bayley, E. B. Brown, S. R. Martin, M. D. Waterfield, J. M. White, I. A. Wilson, and D. C. Wiley. 1982. Changes in the conformation of influenza virus hemmagglutinin at the pH optimum of virus-mediated membrane fusion. Proc. Natl. Acad. Sci. USA. 79:968972.
Skehel, J. J., and D. C. Wiley. 2000. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu. Rev. Biochem. 69:531569.[CrossRef][Medline]
Smith, T. F., and M. S. Waterman. 1981. Identification of common molecular subsequences. J. Mol. Biol. 147:195197.[CrossRef][Medline]
Steinhauer, D. A., S. A. Wharton, J. J. Skehel, and D. C. Wiley. 1995. Studies of the membrane fusion activities of fusion peptide mutants of influenza virus haemagglutinin. J. Virol. 69:66436651.[Abstract]
Tamm, L. 2003. Th. Biochim. Biophys. Acta. 1614:1423.[Medline]
Taylor, W. R. 1998. Dynamic sequence databank searching with templates and multiple alignment. J. Mol. Biol. 280:375406.[CrossRef][Medline]
Thomas, D. J. 1991. A simplified mechanical model of proteins tested on the globin fold. J. Mol. Biol. 222:805817.[CrossRef][Medline]
Thomas, D. J. 1994. The graduation of secondary structure elements. J. Mol. Graph. 12:146152.[CrossRef][Medline]
Tieleman, D., M. Sansom, and H. Berendsen. 1999. Alamethicin helices in a bilayer and in solution: Molecular dynamics simulations. Biophys. J. 76:4049.
Vaccaro, L., K. J. Cross, S. A. Wharton, J. J. Skehel, and F. Fraternali. 2004. Aspects of the fusogenic activity of influenza haemmagglutinin peptides by molecular dynamics simulations. In Viral Membrane Proteins: Structure, Function and Drug Design. W. B. Fischer, editor, Kluwer Academic Plenum, Dordrecht, The Netherlands.
van Gunsteren, W., S. Billeter, A. Eising, P. Hünenberger, P. Krüger, A. Mark, W. Scott, and I. Tironi. 1996. Biomolecular Simulations: The GROMOS96 Manual and User Guide. BIOMOS b.v., Zürich, Groningen.,
Vriend, G. 1990. WHAT IF: a molecular modeling and drug design program. J. Mol. Graph. 8:5255.[CrossRef][Medline]
Wharton, S. A., S. R. Martin, R. W. Ruigrok, J. J. Skehel, and D. C. Wiley. 1988. Membrane fusion by peptide analogues of influenza virus haemagglutinin fusion. J. Gen. Virol. 69:18471857.